Cargando…

Protein Quality Control Pathways at the Crossroad of Synucleinopathies

The pathophysiology of Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, and many others converge at alpha-synuclein (α-Syn) aggregation. Although it is still not entirely clear what precise biophysical processes act as triggers, cumulative evidence points towards a crucial ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Mattos, Eduardo P., Wentink, Anne, Nussbaum-Krammer, Carmen, Hansen, Christian, Bergink, Steven, Melki, Ronald, Kampinga, Harm H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242842/ https://www.ncbi.nlm.nih.gov/pubmed/31985474 http://dx.doi.org/10.3233/JPD-191790

Ejemplares similares

Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species
por: Nachman, Eliana, et al.
Publicado: (2020)

α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
por: Hoppe, Simon Oliver, et al.
Publicado: (2021)

Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch
por: Kuiper, E. F. E., et al.
Publicado: (2017)

DNAJs: more than substrate delivery to HSPA
por: Dekker, Suzanne L., et al.
Publicado: (2015)

Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases
por: Melki, Ronald
Publicado: (2015)

Protein quality control in the nucleolus safeguards recovery of epigenetic regulators after heat shock
por: Azkanaz, Maria, et al.
Publicado: (2019)

Dissecting aggregation and seeding dynamics of α-Syn polymorphs using the phasor approach to FLIM
por: Tittelmeier, Jessica, et al.
Publicado: (2022)

DNAJB6b is Downregulated in Synucleinopathies
por: Folke, Jonas, et al.
Publicado: (2021)

Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
por: Nimmo, Jacqui T., et al.
Publicado: (2020)

FOXO1 controls protein synthesis and transcript abundance of mutant polyglutamine proteins, preventing protein aggregation
por: Furtado, Gabriel Vasata, et al.
Publicado: (2021)

Spreading of a Prion Domain from Cell-to-Cell by Vesicular Transport in Caenorhabditis elegans
por: Nussbaum-Krammer, Carmen I., et al.
Publicado: (2013)

Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
por: Nimmo, Jacqui T., et al.
Publicado: (2023)

γ-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein
por: Ninkina, Natalia, et al.
Publicado: (2009)

DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios
por: Månsson, Cecilia, et al.
Publicado: (2013)

Ena/VASP proteins at the crossroads of actin nucleation pathways in dendritic cell migration
por: Visweshwaran, Sai Prasanna, et al.
Publicado: (2022)

Protocadherins at the Crossroad of Signaling Pathways
por: Pancho, Anna, et al.
Publicado: (2020)

Protein quality control: from mechanism to disease: EMBO Workshop, Costa de la Calma (Mallorca), Spain, April 28 – May 03, 2019
por: Kampinga, Harm H., et al.
Publicado: (2019)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

The Synucleinopathies: Twenty Years On
por: Goedert, Michel, et al.
Publicado: (2017)

Surgical Management of Synucleinopathies
por: Sriram, Sai, et al.
Publicado: (2022)

The Endosomal Recycling Pathway—At the Crossroads of the Cell
por: O’Sullivan, Mary J., et al.
Publicado: (2020)

Mechanisms of Neuronal Death in Synucleinopathy
por: Takeda, Atsushi, et al.
Publicado: (2006)

The Role of Glia in Alpha-Synucleinopathies
por: Fellner, Lisa, et al.
Publicado: (2012)

Autonomic Dysfunction in α-Synucleinopathies
por: Mendoza-Velásquez, José Javier, et al.
Publicado: (2019)

Selective vulnerability in α-synucleinopathies
por: Alegre-Abarrategui, Javier, et al.
Publicado: (2019)

The Pharmacology of Visual Hallucinations in Synucleinopathies
por: Russo, Mirella, et al.
Publicado: (2019)

Neuropathology and molecular diagnosis of Synucleinopathies
por: Koga, Shunsuke, et al.
Publicado: (2021)

Inflammation promotes synucleinopathy propagation
por: Kim, Tae-Kyung, et al.
Publicado: (2022)

Sudden cardiac death in synucleinopathies
por: Javanshiri, Keivan, et al.
Publicado: (2023)

Sleeping Sickness at the Crossroads
por: Burri, Christian
Publicado: (2020)

Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
por: Crews, Leslie, et al.
Publicado: (2010)

Crossroad
por: Paz-Pacheco, Elizabeth
Publicado: (2022)

LAG3 is not expressed in human and murine neurons and does not modulate α‐synucleinopathies
por: Emmenegger, Marc, et al.
Publicado: (2021)

Cytokinin at the Crossroads of Abiotic Stress Signalling Pathways
por: Pavlů, Jaroslav, et al.
Publicado: (2018)

TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration
por: Tondo, Giacomo, et al.
Publicado: (2019)

Decoding the Complex Crossroad of Tryptophan Metabolic Pathways
por: Mondanelli, Giada, et al.
Publicado: (2022)

Histones: At the Crossroads of Peptide and Protein Chemistry
por: Müller, Manuel M., et al.
Publicado: (2014)

RNF11 at the Crossroads of Protein Ubiquitination
por: Mattioni, Anna, et al.
Publicado: (2020)

Gaucher disease and the synucleinopathies: refining the relationship
por: Campbell, Tessa N, et al.
Publicado: (2012)

Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
por: Arotcarena, Marie-Laure, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pn7kqmvo4lp3n94kes3qd2ml92